The World Health Organization recently labeled Roundup weedkiller a probable human carcinogen. Monsanto’s popular product is linked to non-Hodgkin’s lymphoma in farm workers and other agricultural professionals. Our cancer lawyers are now accepting clients who wish to take action against Monsanto.
Dozens of lawsuits filed against the company accuse it of knowing that Roundup could cause cancer and convincing governments, farmers, and the public that it was safe. The main ingredient in Roundup – glyphosate – is an herbicide used to kill weeds on all types of crops, from potatoes, to corn, to lentils and soybeans.
In fact, glyphosate was recently named the most-heavily used agricultural chemical of all time.
It is so widely used that it’s contaminating drinking water, ground soil, women’s breast milk, blood and urine. An analysis found that women in the U.S. had glyphosate levels that were eight times higher than levels in European women. The European Union has refused to approve Roundup’s use, hopefully leading to its total ban.
A woman in Missouri won $55 million in the second ovarian cancer trial against baby powder manufacturer Johnson & Johnson. Baby powder is made from talcum powder, and is linked to ovarian cancer when used genitally. Our talcum powder attorneys are representing women diagnosed with ovarian cancer nationwide.
This is the second talc cancer lawsuit to go to trial this year, and the second multi-million dollar win for plaintiffs. The first suit ended in $72 million to the plaintiff, who tragically passed away from ovarian cancer before trial. Her family was awarded the jury verdict, though her son couldn’t stifle his tears when the award was announced. The woman, Jackie Fox, was only 62 years old.
Baby Powder Lawsuits Explained
Jackie Fox and this most recent plaintiff (who is also 62), Gloria Ristesund, are two of more than 1,200 lawsuits against Johnson & Johnson (J&J). The plaintiffs are women who used J&J’s baby powder genitally and have been diagnosed with ovarian cancer.
This Earth Day, our toxic substance attorneys want to highlight the importance of environmental contamination law. Whether we realize it or not, we encounter chemicals and naturally occurring toxins every single day.
There are currently more than 80,000 chemicals available for use in the U.S.
Our mesothelioma lawyers recently posted a blog about how toxic substances are approved for public consumption and defended in court when they cause health problems. In that post we explain that, of the 80,000 chemicals used today, the EPA has reviewed only 570. That leaves 79,430 chemicals unregulated in the U.S. The chemical industry and other special interests purposefully make it extremely difficult to for the government to assess chemicals. These assessments are necessary to propose regulations. The industry and its paid scientists spend incredible amounts of money stalling these reviews to prevent regulation and increase their profits.
On Thursday, April 7, 2016, the FDA allowed a new device onto market that claims to contain tissue during power morcellator procedures. The device, PneumoLiner, is not proven to reduce the risk of spreading cancer. The uterine cancer lawyers at Pintas & Mullins shed light on this new device and its risks below.
Power morcellators were commonly used during hysterectomies or to remove uterine fibroids until 2014, when outcry from patient advocates and medical experts came to a head. After several studies were published officially linking power morcellators to the spread or uterine cancer, the FDA took steps to warn patients and doctors and limit the risk of aggressive cancer spread.
In November 2014, the FDA ordered new black box warnings for power morcellators and urged doctors to inform their patients that these devices could spread undetected cancer. About one in 350 women who undergo hysterectomies or myomectomies (uterine fibroid removal) have undetected uterine cancer tissue. If morcellation is performed on these women, it could spread the cancerous tissue in the abdomen and pelvis, significantly worsening their likelihood of long-term survival.
The FDA recently recommended a black box warning for the contraceptive Essure, calling attention to the potential for life-threatening and permanent health problems. The agency also ordered Bayer, Essure’s manufacturer, to conduct a new study on the implant’s true risks. The Essure lawyers at Pintas & Mullins are disappointed in the FDA’s failure to protect women from further harm.
Essure is a non-invasive form of permanent birth control approved in 2002. The device is implanted into a woman’s fallopian tubes, causing scar tissue to grow around the device to prevent sperm from reaching eggs, thereby preventing pregnancy.
Essure vs. Tubal Ligation
With 12,000 officers on the Chicago Police force, problematic behavior among some individuals is to be expected. What is more surprising is that a very small fraction – 124 officers – account of a third of all misconduct lawsuits settlements since 2009. The police misconduct lawyers at Pintas & Mullins shed light on this problem, which the city has known of and failed to address for decades.
The Chicago Tribune recently published an investigation into settlements paid to victims of police misconduct. In the last seven years, Chicago has settled more than 1,100 cases, the majority of which for relatively minor incidents, like false arrests, harassment, or injuries inflicted during a traffic stop.
Shockingly, 82% of CPD officers were not named in any of these settlements, and the 124 officers that were identified in one-third of misconduct lawsuits cost the city – meaning its taxpayers – $34 million. These officers are rarely disciplined.
As lawsuits against manufacturers of transvaginal mesh (TVM) products go to trial, our team of TVM lawyers are happy to announce victories on behalf of severely injured women. In one of the latest verdicts, a woman in Delaware was awarded $100 million by a jury, though the judge later reduced the award to $10 million.
The original award to Deborah Barba was the largest ever in a trial involving TVM products. She filed a claim against Boston Scientific, one of seven TVM manufacturers collectively facing more than 100,000 injury lawsuits.
Barba received the mesh in 2009 to treat pelvic organ prolapse (POP) and stress urinary incontinence (SUI). The mesh caused extensive health problems for Barba, including recurring bladder infections, severe pain, and two additional forced surgeries. She filed suit against Boston Scientific in 2011.
Residents of Michigan’s second-largest city recently filed three class action lawsuits against the city, state and federal government. The lawsuits center on Flint’s contaminated water supply. Our team of lead poisoning attorneys detail this water crisis and similar water contamination lawsuits we have handled.
Flint has struggled immensely in recent years, accruing millions of dollars in debt. From 2011 to 2015, Michigan Governor Rick Snyder appointed a series of four Emergency Managers to aid in the city’s financial crisis. Emergency Managers are given unusually broad powers, and as part of the restructuring, in 2014 managers approved switching the public’s water source from Lake Huron to the Flint River, in an effort to save costs.
Residents and Doctors Ignored
For the last 50 years, Flint has relied solely on Detroit to route treated water from Lake Huron for its public water supply. When a new pipeline, from Lake Huron to the Flint area, began construction, Flint officials decided to save money by sourcing its water exclusively from the Flint River until the pipeline’s completion in 2016.
According to C.R. Bard’s internal documents, the company was well aware that its G2, G2 Express and Recovery IVC filters were associated with dozens of deaths and hundreds of injuries. Despite this knowledge, Bard kept its IVC filters on market, selling hundreds of thousands. The IVC filter lawyers are now accepting claims of serious injury from C.R. Bard’s filters.
Interior vena cava (IVC) filters are surgically implanted to stop blood clots from entering the lungs and heart. These filters are typically recommended for patients who cannot tolerate or do not respond to pharmaceutical blood thinners. There are two types of IVC filters: permanent and temporary. Temporary filters are designed to be retrievable, and must be removed as soon as the risk of blood clotting subsides.
Unfortunately, we now know that temporary IVC filters consistently fracture, migrate away from the implant site, and cause serious, life-threatening complications. Thousands of patients have been told their temporary IVC filters cannot be removed due to device defects, leaving them no choice but to live knowing they are implanted with a ticking time bomb.